CLOSE X
Beta Drugs Ltd.
Issue Open Date 29-Sep-17  
Issue Closing Date 04-Oct-17  
Application Money 100  
Allotment Money  
Price Band () 85 -  
Minimum Bid Quantity. 1600  
Issue Size (Shares) 2296000  
Market Lot 1  
Objective

OBJECT OF THE ISSUERequirement of FundsThe proceeds of the Issue, after deducting Issue related expenses, are estimated to be 1951.60 lakhs(the Net Proceeds)We intend to utilize the Net Proceeds towards the following objects:1. Purchase of new plant and machinery and upgradation of our existing plant and machinery.2. Civil Construction work at existing manufacturing unit.3. To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operationScheme certificate4. Working Capital requirements.5. General Corporate Purpose.

Business Description

OVERVIEWBeta Drugs Limited is a part of Adley Group. Adley Group was founded in the year 1985, by our promoterVijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products inIndia. Beta Drugs Limited is , pharmaceutical formulation manufacturing company engaged in developing,manufacturing and marketing of drug products for domestic and international cu...

Promoter's Holding
Total Share Capital    
Offered to Public    
Promoter's Holding (Pre-Issue)    
Promoter's Holding (Post-Issue)    
Address
Address :Village Nandpur
Lodhimajra Road
Distt Solan
City :Baddi, State :Himachal Pradesh Pincode :174101 Phone :01795-236196 Email : cs@betadrugslimited.com Website : www.betadrugslimited.com
Registrar
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
NSE
Lead Manager
Pantomath Capital Advisors Pvt Ltd.
Promoters
Vijay Kumar Batra
BNK Securities Pvt. Ltd

CIN No.:U67120WB1995PTC071182 (ISO 90001:2015 & ISO 27001:2013 Certified Company)

Registered Office: Mayfair Tower, 2,Palm Avenue,Kolkata-700 019

Tel:+91-33-4602-2160/61/62/63 Email:contact@bnkcapital.com

BNK Securities Pvt Ltd. MEMBERS OF NSE, BSE AND MSEI SEBI Registration no: INZ000220037

SEBI Registration No: MB / INM000011641 (Category I Merchant Banker), Research Analyst. Reg no INH300003520

DEPOSITORY PARTICIPANT SEBI Registration No-In-DP-673-2022, CDSL DP ID - 12060500.

AMFI certified Mutual Fund Distributor Registration No: ARN–86507

For any grievances, investors can contact at: grievance@bnkstockline.com, Tel:+91-33-4602-2160/61/62/63

 ©  Copyrights 2022, BNK Capital Group All Rights Reserved

Designed & Developed - Accord Fintech Pvt. Ltd.